|Videos|June 11, 2021

New insight into axial length, data shows

Author(s)Paul Chamberlain, Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director, Brooke Henson, Editor

Emmetropes show axial length growth just like their myopic counterparts, says Paul Chamberlain, director of myopia research programs at CooperVision. He spoke with Optometry Times® Editor in Chief Gretchyn Bailey about how his research was sparked by existing work and what the study results mean for myopia management. Take a look.

Related: CooperVision releases MiSight 6-year data

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Related Content

Stellest lens Image credit: Essilor

Highly aspherical lenslets spectacle lenses slow myopia progression, study supports

ByJordana Joy, Editor

August 28th 2026

Noha Ekdawi, MD, FAAP Image credit: Ekdawi

Not all myopia is the same: Noha Ekdawi, MD, FAAP, on individualized management

ByNoha Ekdawi, MD, FAAP,Kassi Filkins, Editor

August 26th 2026

Carolyn Majcher, OD, FAAO

How Lytenava's FDA approval will impact clinical treatment of nAMD

ByCarolyn Majcher, OD, FAAO,Jordana Joy, Editor,Anita Shiva

August 21st 2026

Katie W. Chu, OD, | Image Credit: LinkedIn/Katie W. Chu

Promoting independence in pediatric eye care patients

ByKatie W. Chu, OD,Jordana Joy, Editor,Anita Shiva

Published: August 18th 2026 | Updated: August 28th 2026

Lindsay Elkins, OD, FAAO, discusses volunteering with Remote Area Medical (RAM) to provide free eye care at pop-up clinics

Remote Area Medical: Lindsay Elkins, OD, FAAO, on care for underserved communities

ByLindsay Elkins, OD, FAAO,Abigail Lewis, Content Intern

August 11th 2026

Latest CME

Medical Crossfire®: Maximizing Durability Across Retinal Disease — What 3 Years of Evidence Means for Your Practice

Medical Crossfire®: Maximizing Durability Across Retinal Disease — What 3 Years of Evidence Means for Your Practice

Judy E. Kim, MD, FARVO, FASRS; Anat Loewenstein, MD, MHA; Deepak Sambhara, MD, FASRS

AREDS3 and Beyond: The Scientific Basis for B Vitamin Nutritional Supplementation in AMD

In-Person + Virtual Event

AREDS3 and Beyond: The Scientific Basis for B Vitamin Nutritional Supplementation in AMD

September 13, 2026

EyeCon 2026

EyeCon 2026

September 26, 2026

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

SriniVas R. Sadda, MD, FARVO; Mark R. Barakat, MD, FASRS; David A. Eichenbaum, MD, FASRS

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Stephen C. Pflugfelder, MD; Cecelia Koetting, OD, FAAO, DipABO

(COPE Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

(COPE Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Stephen C. Pflugfelder, MD; Cecelia Koetting, OD, FAAO, DipABO

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Basil Williams, MD; Maura Di Nicola, MD

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

John Kitchens, MD; Michael W. Stewart, MD

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Deep Parikh, MD

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Dilsher S. Dhoot, MD, FASRS

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

Mile Brujic, OD, FAAO; Pierce Kenworthy, OD, FAAO; Blair Lonsberry, MS, OD, MEd, FAAO

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

Uday Devgan, MD, FACS, FRCS

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

(CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

(CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

Damon Dierker, OD FAAO; Maria Pribis, OD

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

FDA accepts NDA for bimatoprost grenod in open-angle glaucoma and OHT

Highly aspherical lenslets spectacle lenses slow myopia progression, study supports

Takeaways from this week in optometry: August 24-28

Catching keratoconus early in pediatric patients: Why timing matters

Back to school roundup: Setting up for success